Diagnosis of HIV/AIDS - Quiz
A) Saliva, mucus, or blood plasma B) Urine, sweat, or saliva C) Serum, saliva, or urine D) Sweat, tears, or serum
A) DNA, proteins, or antibodies B) RNA, hormones, or antibodies C) Antibodies, antigens, or RNA D) Antigens, enzymes, or cells
A) Below 500 cells per μL B) Below 300 cells per μL C) Below 100 cells per μL D) Below 200 cells per μL
A) 18 days B) 1 day C) 11.5 days D) 200 days
A) 2.5 million days B) 18 days C) 200 days D) 11.5 days
A) The number of antibodies present in the serum B) The time it takes to detect the virus C) Percentage of results that are positive when HIV is present D) Percentage of results that are negative when HIV is absent
A) Percentage of results that are positive when HIV is present B) The duration of the eclipse period C) The ability of a test to identify RNA D) Percentage of results that are negative when HIV is not present
A) Test incorrectly indicates HIV is absent in an infected person B) Test correctly identifies a non-infected person C) Test incorrectly indicates HIV is present in a non-infected person D) Test fails to detect the virus during the window period
A) Test incorrectly indicates HIV is present in a non-infected person B) Test incorrectly indicates HIV is absent in an infected person C) Test fails due to hypergammaglobulinemia D) Test correctly identifies an infected person
A) The window period B) Autoimmune diseases C) The eclipse period D) High CD4+ T cell counts
A) Nonspecific reactions B) The window period C) Hypergammaglobulinemia D) Systemic lupus erythematosus
A) To reduce the cost of testing B) To ensure HIV is detected if present C) To shorten the eclipse period D) To identify autoimmune diseases
A) Only nucleic acid tests B) Antibody, antigen, and nucleic acid tests C) Only antibody tests D) Only antigen tests
A) 11.5 million B) 2.5 million C) 200,000 D) 1 million
A) Combination of antibody testing (EIA) and nucleic acid testing (NAT) B) Only antibody testing (EIA) C) Visual inspection of blood samples D) Only nucleic acid testing (NAT)
A) Approximately one in 11.5 million B) Approximately one in 2.5 million C) Approximately one in 1 million D) Approximately one in 18 million
A) A period starting from exposure in which no test can detect HIV B) The time required for CD4+ cells to drop below 200 C) The time between exposure and positive antibody test D) A clinical condition of immunosuppression
A) HIV-1, HIV-2, and HIV-3 B) HIV-1 and HIV-2 C) Only HIV-1 D) Only HIV-2
A) Development of an AIDS-defining clinical condition B) A CD4+ T cell count above 500 cells per μL C) A positive test result during the eclipse period D) Presence of nonspecific reactions in the blood
A) Polymerase chain reaction B) Rapid antibody strip test C) ELISA D) Western blot
A) Public notification B) Compulsory treatment C) Mandatory reporting to police D) Informed consent
A) Automatic insurance enrollment B) Immediate quarantine C) Mandatory workplace notification D) Accompanied by counseling
A) A fingerprint B) A social security number C) A medical record ID D) A number
A) 16–60 B) 18–65 C) 12–70 D) 13–64
A) 5% B) 25% C) 50% D) 10%
A) New York B) Texas C) California D) Florida
A) 90% B) 99% C) 50% D) 75%
A) Only after the window period ends B) Yes C) Only if symptoms are present D) No
A) Enzyme-level immune system analysis B) Extended linkage internal serum assay C) Enhanced laboratory immunological screening assay D) Enzyme-linked immunosorbent assay
A) 100-fold B) 400-fold C) 200-fold D) 1000-fold
A) The time taken for analysis B) The storage of HIV antigens C) The cost of the reagents D) Determining the cut-off point
A) Stanford University B) Columbia University C) Harvard University D) Oxford University
A) Five minutes B) Fifteen minutes C) Thirty minutes D) One hour
A) Sodium lauryl sulfate B) Cellulose acetate C) Recombinant DNA D) Secondary antibody enzyme
A) Equivocal-positive B) Indeterminate C) Inconclusive failure D) False negative
A) Recombinant immunoblot assay B) Radioactive immunoblot analysis C) Recombinant internal biological assay D) Rapid immunosorbent blot assay
A) One year B) One month C) Six months D) Three months
A) Ignore the result B) Perform a blood transfusion C) Get retested D) Start HIV medication immediately
A) Hepatitis C B) Malaria C) Syphilis D) Tuberculosis
A) Low-risk populations B) High-risk populations C) Patients with acute symptoms D) Populations in endemic areas
A) A physician's observation only B) Multi-test algorithms C) A single rapid test D) A patient's self-report
A) Confirm the result using the western blot B) Ignore the result as a false positive C) Start HIV treatment immediately D) Retest using the same rapid test kit
A) Western blot B) A rapid combination antigen/antibody test C) A second ELISA test D) A blood cell count
A) The rate increases significantly B) The rate remains unchanged C) The rate becomes unpredictable D) The rate becomes extremely low
A) Stop all future testing B) Assume they are HIV positive C) Be re-tested at a later date D) Assume they are HIV negative |
Created with That Quiz —
a math test site for students of all grade levels.